MX364766B - Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina. - Google Patents

Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.

Info

Publication number
MX364766B
MX364766B MX2017007614A MX2017007614A MX364766B MX 364766 B MX364766 B MX 364766B MX 2017007614 A MX2017007614 A MX 2017007614A MX 2017007614 A MX2017007614 A MX 2017007614A MX 364766 B MX364766 B MX 364766B
Authority
MX
Mexico
Prior art keywords
preparation
diiodo
tyrosine
iodophenyl
compound
Prior art date
Application number
MX2017007614A
Other languages
English (en)
Inventor
Lattuada Luciano
Lucio Anelli Pier
Argese Maria
Boi Valeria
Cavalieri Livio
Galimberti Laura
Gazzetto Sonia
Maisano Federico
Rivolta Giovanni
Vella Fulvia
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/083,047 external-priority patent/US20110245342A1/en
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Priority claimed from PCT/EP2012/056274 external-priority patent/WO2012136761A1/en
Publication of MX364766B publication Critical patent/MX364766B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/24—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfuric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/08—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/04—Sodium compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona a un proceso para la preparación de la sal monosódica del derivado 3,5- diiodo-O-[3-iodo-4-(sulfooxi) fenil]-L-tirosina (T3S) iniciando del compuesto fenólico correspondiente, en presencia de ácido clorosulfónico y dimetilacetamida como un solvente. El T3S así obtenido se puede aislar convenientemente en una forma pura como un sólido en producciones buenas. La presente invención además se relaciona al proceso para la preparación de T3S, en donde el reactivo de inicio es T2 y además comprende la formulación del compuesto en comprimidos. Además, la invención describe inmuno-ensayos no radioactivos con base en derivados de T3S.
MX2017007614A 2011-04-08 2012-04-05 Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina. MX364766B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/083,047 US20110245342A1 (en) 2002-11-13 2011-04-08 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
IT000713A ITMI20110713A1 (it) 2011-04-29 2011-04-29 Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
PCT/EP2012/056274 WO2012136761A1 (en) 2011-04-08 2012-04-05 Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine

Publications (1)

Publication Number Publication Date
MX364766B true MX364766B (es) 2019-05-06

Family

ID=44555080

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007614A MX364766B (es) 2011-04-08 2012-04-05 Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.

Country Status (7)

Country Link
US (3) US9890116B2 (es)
ES (1) ES2831408T3 (es)
HU (1) HUE036991T2 (es)
IL (1) IL260578B (es)
IT (1) ITMI20110713A1 (es)
MX (1) MX364766B (es)
RU (2) RU2662826C1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
US20160161473A1 (en) * 2014-12-08 2016-06-09 Calbiotech, Inc. Biotin conjugates of analytes containing amino, hydroxyl, or thiol functional groups for use in immunodiagnostic assays

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993928A (en) 1957-01-15 1961-07-25 Glaxo Lab Ltd Preparation of triiodothyronine
US2970165A (en) * 1957-10-01 1961-01-31 Warner Lambert Pharmaceutical Sulfate compounds
US3313839A (en) * 1963-07-01 1967-04-11 Gen Aniline & Film Corp Preparation of sulfate esters by the reaction of chlorosulfonic acid with alkoxylated alkyl phenols
US3313838A (en) * 1963-07-01 1967-04-11 Gen Aniline & Film Corp Reaction of chlorosulfonic acid with alkoxylated alkyl phenols
US4031622A (en) 1975-10-28 1977-06-28 Wells Manufacturing Corporation Portable power driven implement
US4254095A (en) 1978-04-27 1981-03-03 Research Corporation Radioimmunoassay for erythropoietin
US5385897A (en) * 1985-08-09 1995-01-31 Roussel-Uclaf 4-thia-1-aza-bicyclo[4,2,0]oct-2-ene derivatives
JPH07116031B2 (ja) 1986-09-24 1995-12-13 株式会社アドバンス 制癌剤
US5116828A (en) 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5158978A (en) 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
CA2051369C (en) 1990-02-05 2002-01-01 Leo Rubin Thyroid hormone cardiac treatment
US5272078A (en) 1991-01-29 1993-12-21 Brigham And Women's Hospital CDNA encoding the type I iodothyronine 5'deiodinase
US6498037B1 (en) 1991-03-04 2002-12-24 Bayer Corporation Method of handling reagents in a random access protocol
US5225204A (en) 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
DK0550108T3 (da) 1991-12-30 1999-01-04 Akzo Nobel Nv Thyreoaktiv sammensætning med langvarig frigivelse
KR950010051Y1 (ko) 1993-10-15 1995-11-25 이해섭 휴대용 절첩테이블
GB9401892D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
JPH0816031A (ja) 1994-06-30 1996-01-19 Toshiba Corp 熱定着装置
DE19541128C2 (de) 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
BR9611306A (pt) 1995-11-14 1999-12-28 Knoll Pharmaceuticals Co Preparação farmacêutica e, composto farmacêutica estável.
WO1999042838A1 (en) 1998-02-18 1999-08-26 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
DE19821625C1 (de) 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
IT1302201B1 (it) * 1998-09-11 2000-07-31 Bracco Spa Processo per la produzione di ormoni tiroidei.
US6599942B1 (en) 1999-03-29 2003-07-29 Novartis Ag Thyromimetic organic compounds
US6740680B1 (en) 1999-04-26 2004-05-25 Becton Pharma, Inc. Pharmaceutical compositions to tetrac and methods of use thereof
US6664291B2 (en) 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
AU2001278034A1 (en) 2000-07-26 2002-02-05 Bio-Diagnostics Inc. Method for diagnosing thyroid conditions and for monitoring thyroxine therapy
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US20030224047A1 (en) 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
ITMI20011401A1 (it) 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
DE10136615A1 (de) 2001-07-17 2003-02-06 Berlin Chemie Ag Schilddrüsentherapeutika
US20030195253A1 (en) 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
GB0215978D0 (en) * 2002-07-10 2002-08-21 Karobio Ab Novel compounds
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20022777A1 (it) 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
US20040156893A1 (en) 2003-02-11 2004-08-12 Irwin Klein Method for treating hypothyroidism
US8293272B2 (en) 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
RU2361573C2 (ru) 2003-05-02 2009-07-20 Глобофарм Фармацойтише Продукционс-Унд Хандельсгезелльшафт М.Б.Х. Твердая фармацевтическая композиция с содержанием солей левотироксина и/или лиотиронина
RU2006100301A (ru) * 2003-06-11 2006-07-10 Санкио Компани Лимитед (JP) Соединение циклического третичного амина
GB0316206D0 (en) 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
PL2801354T3 (pl) 2004-10-08 2017-08-31 Forward Pharma A/S Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające ester kwasu fumarowego
AU2007267612A1 (en) 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
PT1958617E (pt) 2007-02-14 2010-10-28 Lesvi Laboratorios Sl Composições farmacêuticas contendo fumarato de quetiapina
AU2008240374A1 (en) 2007-04-23 2008-10-30 Diurnal Limited Sustained release
EP1992341A1 (en) 2007-05-16 2008-11-19 Université Joseph Fourier New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
WO2008140459A1 (en) 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2009123580A1 (en) * 2008-04-01 2009-10-08 Schering-Plough Healthcare Products, Inc. Chewable tablet and method of formulating
FR2931359B1 (fr) 2008-05-20 2012-12-21 Menvielle Bourg Fabienne Joanny Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice
KR20120027197A (ko) 2009-04-01 2012-03-21 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
CN102259831A (zh) 2010-05-27 2011-11-30 清华大学 三维纳米结构阵列

Also Published As

Publication number Publication date
IL260578B (en) 2020-06-30
RU2708244C1 (ru) 2019-12-05
US10457635B2 (en) 2019-10-29
HUE036991T2 (hu) 2018-08-28
US20140024717A1 (en) 2014-01-23
US20180118669A1 (en) 2018-05-03
ES2831408T3 (es) 2021-06-08
US20140221477A1 (en) 2014-08-07
RU2662826C1 (ru) 2018-07-31
ITMI20110713A1 (it) 2012-10-30
US9890116B2 (en) 2018-02-13

Similar Documents

Publication Publication Date Title
AU2013380573A8 (en) A process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
MX2016006336A (es) Compuestos pirazolopirimidina.
CA2875877C (en) Syk inhibitors
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
MA35664B1 (fr) Nouveaux dérivés bicycliques de la dihydroisoquinoline-1-one
MX2013014846A (es) Benzoxazepinonas fusionadas como moduladoras de canales ionicos.
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
EA201591527A1 (ru) Новые производные пиридина
RS51210B (sr) Dobijanje pregaballina i srodnih jedinjenja
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
WO2014120861A3 (en) Method off preparing oligomeric compounds
GEP201706749B (en) Vortioxetine manufacturing process
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
IN2014DN05972A (es)
IN2014DN00144A (es)
BR102014005754B8 (pt) composto,e, método para a preparação de um composto
MX364766B (es) Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
WO2011157388A8 (en) Process for the preparation of pteridine derivatives
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds